IRRIV International Renal Research Institute Vicenza

 

38th Vicenza Course on AKI and CRRT
A

Why Should We Utilize Continuous Venovenous Hemodialysis as Modality for Regional Citrate Anticoagulation?

By 38th Vicenza Course on AKI and CRRT FEATURING Antoine G. Schneider
By 38th Vicenza Course on AKI and CRRT FEATURING Antoine G. Schneider
68 views
February 3, 2021
0 Comments
Login to view comments. Click here to Login
38th Vicenza Course on AKI and CRRT
15:47
38th Vicenza Course on AKI and CRRT

Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker in …

Feat. C. Albert, K. Doi
14:26
38th Vicenza Course on AKI and CRRT

Septic AKI: Can Dialysis Membranes Be Used as a Therapeutic Approach?

Feat. V. Cantaluppi
11:50
38th Vicenza Course on AKI and CRRT

Procoagulant State with COVID-19: Do We Need to Adapt Anticoagulatio…

Feat. A. G. Schneider
12:54
38th Vicenza Course on AKI and CRRT

Citrate vs. Heparin Anticoagulation in CRRT: What to Recommend?

Feat. D. Khadzhynov
13:30
38th Vicenza Course on AKI and CRRT

The Clinical Path for CRRT NICU Adoption: How To Know When the Risks…

Feat. S. Goldstein
18:52
38th Vicenza Course on AKI and CRRT

How CARPEDIEM Helps Increase Adoption of Continuous Renal Replacemen…

Feat. E. Vidal
14:36
38th Vicenza Course on AKI and CRRT

Polymyxin B HemoPerfusion Therapy for Endotoxemia: Does it Have a Ro…

Feat. S. Lucio Cutuli
15:54
38th Vicenza Course on AKI and CRRT

Cytokine Removal Therapy: What Is Its Role in The Treatment of Sepsi…

Feat. F. Sanchez Moran
06:15
38th Vicenza Course on AKI and CRRT

79 y/o Male with Bacterial Septic Shock Treated With Renal Replaceme…

Feat. F. Sanchez Moran
12:24
38th Vicenza Course on AKI and CRRT

Extra-Corporeal Blood Purification in Critically Ill Septic Patients…

Feat. A. Armaganidis
17:40
38th Vicenza Course on AKI and CRRT

Endotoxic Shock and COVID-19: What Is The Role of Polymyxin B Hemope…

Feat. S. De Rosa
17:47
38th Vicenza Course on AKI and CRRT

What Is the Use of Biomarkers for the Management of AKI In the Criti…

Feat. L. G Forni
21:48
38th Vicenza Course on AKI and CRRT

Can Biomarkers Be Utilized in the Management of Cardiac Surgery Asso…

Feat. D. T. Engelman
11:47
38th Vicenza Course on AKI and CRRT

Why Should We Utilize Continuous Venovenous Hemodialysis as Modality…

Feat. A. G. Schneider
12:42
38th Vicenza Course on AKI and CRRT

Interventional Clinical Trial: Does Extracorporeal CO2 Improve Renal…

Feat. V. Marco Ranieri
08:45
38th Vicenza Course on AKI and CRRT

The Unknown Relevance of Endotoxemia and Patients with COVID-19: Doe…

Feat. D. Yamane
11:33
38th Vicenza Course on AKI and CRRT

Endotoxemia and COVID-19 Experiences From the Stony Brook University…

Feat. S. Mallipattu
17:45
38th Vicenza Course on AKI and CRRT

Comparing AKI in Sepsis and AKI in Patients With COVID-19: What Are …

Feat. P. Pickkers
17:36
38th Vicenza Course on AKI and CRRT

Overview of The World Registry for RRT: Can We Manipulate the Immune…

Feat. S. Romagnoli